CORRESP Filing
Autonomix Medical, Inc.
Date: Sept. 4, 2025 · CIK: 0001617867 · Accession: 0001437749-25-028388
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289741
Letter
amix20250904_corresp.htm
Autonomix Medical, Inc.
21 Waterway Avenue, Suite 300
The Woodlands, Texas 77380
September 4, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Re:
Autonomix Medical, Inc.
Registration Statement on Form S-1
Registration No. 333-289741
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Autonomix Medical, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 P.M. (Eastern Time) on September 8, 2025, or as soon thereafter as possible on such date.
Very truly yours,
Autonomix Medical, Inc.
Show Raw Text
CORRESP 1 filename1.htm amix20250904_corresp.htm Autonomix Medical, Inc. 21 Waterway Avenue, Suite 300 The Woodlands, Texas 77380 September 4, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance Washington, DC 20549 Re: Autonomix Medical, Inc. Registration Statement on Form S-1 Registration No. 333-289741 Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Autonomix Medical, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 P.M. (Eastern Time) on September 8, 2025, or as soon thereafter as possible on such date. Very truly yours, Autonomix Medical, Inc. By: /s/ Trent Smith Name: Trent Smith Title: Chief Financial Officer